Drug and alternative therapies for hyperlipidemia
- 31 August 1994
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 108, S105-S116
- https://doi.org/10.1016/0021-9150(94)90156-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trialArchives of internal medicine (1960), 1994
- A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patientsPublished by American Medical Association (AMA) ,1994
- Macrophage colony-stimulating factor regulates both activities of neutral and acidic cholesteryl ester hydrolases in human monocyte-derived macrophages.Journal of Clinical Investigation, 1993
- Effects of One Year of Treatment with Pravastatin, an HMG‐CoA Reductase Inhibitor, on Lipoprotein aThe Journal of Clinical Pharmacology, 1993
- Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption systemThe American Journal of Cardiology, 1992
- Role of fibric acids in the management of hyperlipidemiaCurrent Opinion in Lipidology, 1990
- The HMG CoA reductase inhibitorsCurrent Opinion in Lipidology, 1990
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1981
- PORTACAVAL SHUNT IN FOUR PATIENTS WITH HOMOZYGOUS HYPERCHOLESTEROLÆMIAThe Lancet, 1975